May. 18, 2021 News

Sonavi Labs is pleased to announce that Leslie Wise has joined the company as an official board member. As an authority on healthcare reimbursement policy, health technology assessment, and market access, Leslie possesses a deep knowledge of US and OUS territory HTA, reimbursement, and tendering processes.

Clinical strategy, protocol development, regulatory and reimbursement alignment, value proposition development, health economic outcomes research, coding requirement, patient engagement, professional clinical guidelines, patient care pathways, care delivery efficiency, and quality metrics are all part of Leslie’s vast experience. Since the early 2000s, Leslie has worked for various organizations, including Bristol-Myers Squibb, Biomet, and Angio Dynamics, and is Principal Consultant at Evidencematters, working with medtech, life science, and digital health clients to achieve successful product commercialization.